Related Experiment Videos
Intraoperative radiation therapy for curatively resected rectal cancer
S Sadahiro1, T Suzuki, K Ishikawa
1Department of Surgery and Department of Radiology, Tokai University School of Medicine, Kanagawa, Japan.
Diseases of the Colon and Rectum
|November 17, 2001
Summary
Intraoperative radiotherapy improved survival and reduced local recurrence in rectal cancer patients. This rectal cancer treatment showed significant benefits for Stage II and III patients, particularly in local control.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Locally advanced rectal cancer requires effective local control strategies.
- Intraoperative radiotherapy (IORT) is a technique explored for enhancing local tumor control.
Purpose of the Study:
- To evaluate the efficacy of intraoperative radiotherapy in patients with curatively resected rectal cancer.
- To assess the impact of IORT on survival, disease-free survival, and local recurrence rates.
Main Methods:
- A retrospective comparison of 78 patients receiving IORT with curative resection versus 248 patients treated with surgery alone.
- IORT involved electron beam administration to the pelvic dissected surface, with 62 patients also receiving preoperative radiotherapy.
- Patient groups were compared for survival, disease-free survival, local recurrence, and distant metastasis rates.
Main Results:
- The intraoperative radiotherapy group demonstrated significantly better survival, disease-free survival, and local recurrence-free survival (P=0.01, P=0.04, P=0.02).
- Local failure rates were significantly lower in the IORT group (2.6%) compared to the non-IORT group (11.3%, P=0.02).
- Improved survival was noted in Stage II patients, while local recurrence reduction was observed in Stage II and III patients. Wound infections were more frequent but not serious.
Conclusions:
- Intraoperative radiotherapy, applied to the dissected pelvic surface, effectively reduces local recurrence in Stage II and III rectal adenocarcinoma.
- IORT demonstrated an improvement in survival outcomes, particularly for Stage II rectal cancer patients.
- This rectal cancer treatment strategy offers a valuable option for improving local control and survival in select patient populations.